期刊
EMBO REPORTS
卷 22, 期 10, 页码 -出版社
WILEY
DOI: 10.15252/embr.202152450
关键词
interferon-beta; interferon-stimulated gene; ISG20; placenta trophoblast; ZIKA virus
资金
- NIH grant NIAID [1R01AI145829-01]
The study identified ISG20 as a key component in controlling Zika virus infection and successfully developed a recombinant ISG20-Fc protein that could potentially serve as an antiviral treatment option for high-risk populations, especially pregnant women.
Zika virus is a positive-sense single-stranded RNA virus, which can be transmitted across the placenta and has adverse effects on fetal development during pregnancy. The severity of these complications highlights the importance of prevention and treatment. However, no vaccines or drugs are currently available. In this study, we characterize the IFN beta-mediated anti-viral response in trophoblast cells in order to identify critical components that are necessary for the successful control of viral replication and determine whether components of the IFN-induced response can be used as a replacement therapy for ZIKA virus infection during pregnancy. We identify and characterize interferon-stimulated gene 20 (ISG20) as playing a central role in controlling Zika virus infection in trophoblast cells and successfully establish a recombinant ISG20-Fc protein that effectively decreases viral titers in vitro and in vivo by maintaining its exonuclease activity and displaying potential immune modulatory functions. Recombinant ISG20-Fc has thus the potential to be further developed as an anti-viral treatment against ZIKA viral infection in high-risk populations, particularly in pregnant women.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据